NCT03834337View on ClinicalTrials.gov

Treatment of Patients With Active Neurocysticercosis in Eastern Africa

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Neurocysticercosis
Trial Locations (1)

Unknown

National Institute of Medical Research, Dar es Salaam

All Listed Sponsors
collaborator

National Institute for Medical Research, Tanzania

OTHER_GOV

collaborator

University of Zambia

OTHER

collaborator

Sokoine University of Agriculture

OTHER

lead

Technical University of Munich

OTHER

NCT03834337 - Treatment of Patients With Active Neurocysticercosis in Eastern Africa | Biotech Hunter | Biotech Hunter